Signe Modvig (S Modvig)

Years Active: 2020-2024
Publications (10 Years): 3

This page only lists publications with an associated author ORCID identifier.

Publications

Hanna Thorsson, Rasmus Henningsson, Noelia Puente-Moncada, Pablo Peña-Martinez, Ludvig Sjöström, Helena Ågerstam, Carl Sandén, Marianne Rissler, Anders Castor, Hanne Vibeke Hansen Marquart, Signe Modvig, Kajsa Paulsson, Cornelis J H Pronk, Kjeld Schmiegelow, Axel Hyrenius-Wittsten, Christina Orsmark-Pietras, Henrik Lilljebjorn, Thoas Fioretos
Single-cell genomics details the maturation block in BCP-ALL and identifies therapeutic vulnerabilities in DUX4-r cases. Blood (2024)
Signe Modvig, Rasmus Wernersson, Nina Friesgaard Øbro, Lars Rønn Olsen, Claus Christensen, Susanne Rosthøj, Matilda Degn, Gitte Wullf Jürgensen, Hans O Madsen, Birgitte Klug Albertsen, Peder Skov Wehner, Steen Rosthøj, Henrik Lilljebjörn, Thoas Fioretos, Kjeld Schmiegelow, Hanne Vibeke Marquart
High CD34 surface expression in BCP-ALL predicts poor induction therapy response and is associated with altered expression of genes related to cell migration and adhesion. Molecular oncology 16 (10) (2022)
Signe Modvig, H Hallböök, H O Madsen, S Siitonen, S Rosthøj, Anne Tierens, V Juvonen, L T N Osnes, H Vålerhaugen, M Hultdin, R Matuzeviciene, M Stoskus, M Marincevic, A Lilleorg, M Ehinger, U Norén-Nystrøm, N Toft, M Taskinen, O G Jónsson, K Pruunsild, G Vaitkeviciene, K Vettenranta, B Lund, J Abrahamsson, A Porwit, Kjeld Schmiegelow, Hanne Vibeke Hansen Marquart
Value of flow cytometry for MRD-based relapse prediction in B-cell precursor ALL in a multicenter setting. Leukemia 35 (7) (2020)

Signe Modvig.css-eqlu8i{font-size:small;padding-left:4px;} (S Modvig)